First Trust NYSE Arca Biotechnology Index Fund
FBT
79 hedge funds and large institutions have $541M invested in First Trust NYSE Arca Biotechnology Index Fund in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 4 closing their positions.
400% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 4
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
103% more call options, than puts
Call options by funds: $4.11M | Put options by funds: $2.03M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more funds holding
Funds holding: 64 → 79 (+15)
22% more capital invested
Capital invested by funds: $445M → $541M (+$95.9M)
1.35% more ownership
Funds ownership: 54.27% → 55.61% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$16.9M |
| 2 |
Goldman Sachs
New York
|
+$11.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$8.98M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$7.61M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$5.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMM
Stadion Money Management
Watkinsville,
Georgia
|
-$2.77M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.03M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$994K |
| 4 |
SAG
Sterne Agee Group
Birmingham,
Alabama
|
-$985K |
| 5 |
WA
WESPAC Advisors
Orinda,
California
|
-$410K |
FBT Hedge Fund Activity: Q4 2013 in Review
79 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2013, worth a combined $541M — up 22% from $445M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FBT positions and 4 closed out — a net gain of 16 holders — while 36 added to existing stakes and 17 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $16.9M. The largest seller was Stadion Money Management, exiting entirely with an estimated $2.77M sold.
- 79 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2013, up from 64 in Q3 2013.
- Funds reported $541M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2013, up 22% quarter-over-quarter.
- 20 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2013 and 4 closed out, a net change of +16 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2013 was Morgan Stanley, an estimated $16.9M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2013 was Stadion Money Management, an estimated $2.77M sold.
Based on aggregated 13F filings for Q4 2013.